| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.27 | 5e-07 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 4e-05 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.21 | 7e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |